Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Jan 18;82(2):354–360. doi: 10.1054/bjoc.1999.0926

Hormonally-regulated proteins in breast secretions are markers of target organ sensitivity

C Harding 1, O Osundeko 2, L Tetlow 2, E B Faragher 3, A Howell 4, N J Bundred 1
PMCID: PMC2363294  PMID: 10646888

Abstract

Anti-oestrogen therapy is being used in an attempt to prevent breast cancer but no intermediate end points of the effect of tamoxifen on the normal breast are available. Therefore, the purpose of this study was to develop a physiological measure of oestrogen action on the breast. We measured oestrogen-stimulated and -inhibited proteins in breast secretions from women on and off anti-oestrogen therapy. Two oestrogen-stimulated proteins (pS2 and cathepsin D) and oestrogen-inhibited proteins (CP15, gross cystic disease fluid protein 15; Apo ,: apolipoprotein D) were measured. Premenopausal women had significantly higher pS2 and cathepsin D in association with lower Apo D and CP15 secretion levels compared to post-menopausal women. Sequential nipple aspirates from women treated with the luteinizing hormone releasing hormone agonist goserelin (n = 9), tamoxifen (n = 9) and hormone replacement therapy (HRT) (n = 26) were measured. Following treatment with goserelin, median nipple secretion levels of pS2 fell (P< 0.02) and Apo D and CP15 rose significantly (P< 0.03 and P< 0.05 respectively). Similar changes were seen on tamoxifen therapy but not in untreated control women. Treatment with HRT resulted in a rise of pS2 (P< 0.001) and a fall in Apo D (P< 0.05). Measurement of pS2 and Apo D in nipple aspirates may prove useful intermediate end point of breast responsiveness to anti-oestrogens. © 2000 Cancer Research Campaign

Keywords: breast

Full Text

The Full Text of this article is available as a PDF (91.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergkvist L., Adami H. O., Persson I., Hoover R., Schairer C. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med. 1989 Aug 3;321(5):293–297. doi: 10.1056/NEJM198908033210505. [DOI] [PubMed] [Google Scholar]
  2. Brown A. M., Jeltsch J. M., Roberts M., Chambon P. Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc Natl Acad Sci U S A. 1984 Oct;81(20):6344–6348. doi: 10.1073/pnas.81.20.6344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bulbrook R. D., Hayward J. L., Wang D. Y., Thomas B. S., Clark G. M., Allen D. S., Moore J. W. Identification of women at high risk of breast cancer. Breast Cancer Res Treat. 1986;7 (Suppl):S5–10. [PubMed] [Google Scholar]
  4. Cavailles V., Augereau P., Garcia M., Rochefort H. Estrogens and growth factors induce the mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells. Nucleic Acids Res. 1988 Mar 25;16(5):1903–1919. doi: 10.1093/nar/16.5.1903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cavailles V., Garcia M., Rochefort H. Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells. Mol Endocrinol. 1989 Mar;3(3):552–558. doi: 10.1210/mend-3-3-552. [DOI] [PubMed] [Google Scholar]
  6. Chalbos D., Haagensen D., Parish T., Rochefort H. Identification and androgen regulation of two proteins released by T47D human breast cancer cells. Cancer Res. 1987 Jun 1;47(11):2787–2792. [PubMed] [Google Scholar]
  7. Ernster V. L., Wrensch M. R., Petrakis N. L., King E. B., Miike R., Murai J., Goodson W. H., 3rd, Siiteri P. K. Benign and malignant breast disease: initial study results of serum and breast fluid analyses of endogenous estrogens. J Natl Cancer Inst. 1987 Nov;79(5):949–960. [PubMed] [Google Scholar]
  8. Haagensen D. E., Jr, Dilley W. G., Mazoujian G., Wells S. A., Jr Review of GCDFP-15. An apocrine marker protein. Ann N Y Acad Sci. 1990;586:161–173. doi: 10.1111/j.1749-6632.1990.tb17804.x. [DOI] [PubMed] [Google Scholar]
  9. Hunt K., Vessey M., McPherson K., Coleman M. Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynaecol. 1987 Jul;94(7):620–635. doi: 10.1111/j.1471-0528.1987.tb03166.x. [DOI] [PubMed] [Google Scholar]
  10. Key T. J., Pike M. C. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol. 1988 Jan;24(1):29–43. doi: 10.1016/0277-5379(88)90173-3. [DOI] [PubMed] [Google Scholar]
  11. LIPSETT M. B., BERGENSTAL D. M. Lack of effect of human growth hormone and ovine prolactin on cancer in man. Cancer Res. 1960 Sep;20:1172–1178. [PubMed] [Google Scholar]
  12. Meyer F., Brown J. B., Morrison A. S., MacMahon B. Endogenous sex hormones, prolactin, and breast cancer in premenopausal women. J Natl Cancer Inst. 1986 Sep;77(3):613–616. doi: 10.1093/jnci/77.3.613. [DOI] [PubMed] [Google Scholar]
  13. Petrakis N. L., Ernster V. L., Sacks S. T., King E. B., Schweitzer R. J., Hunt T. K., King M. C. Epidemiology of breast fluid secretion: association with breast cancer risk factors and cerumen type. J Natl Cancer Inst. 1981 Aug;67(2):277–284. [PubMed] [Google Scholar]
  14. Petrakis N. L., Lowenstein J. M., Wiencke J. K., Lee M. M., Wrensch M. R., King E. B., Hilton J. F., Miike R. Gross cystic disease fluid protein in nipple aspirates of breast fluid of Asian and non-Asian women. Cancer Epidemiol Biomarkers Prev. 1993 Nov-Dec;2(6):573–579. [PubMed] [Google Scholar]
  15. Petrakis N. L. Physiologic, biochemical, and cytologic aspects of nipple aspirate fluid. Breast Cancer Res Treat. 1986;8(1):7–19. doi: 10.1007/BF01805919. [DOI] [PubMed] [Google Scholar]
  16. Petrakis N. L., Wrensch M. R., Ernster V. L., Miike R., Murai J., Simberg N., Siiteri P. K. Influence of pregnancy and lactation on serum and breast fluid estrogen levels: implications for breast cancer risk. Int J Cancer. 1987 Nov 15;40(5):587–591. doi: 10.1002/ijc.2910400502. [DOI] [PubMed] [Google Scholar]
  17. Potten C. S., Watson R. J., Williams G. T., Tickle S., Roberts S. A., Harris M., Howell A. The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer. 1988 Aug;58(2):163–170. doi: 10.1038/bjc.1988.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rajah T. T., Dunn S. T., Pento J. T. The influence of antiestrogens on pS2 and cathepsin D mRNA induction in MCF-7 breast cancer cells. Anticancer Res. 1996 Mar-Apr;16(2):837–842. [PubMed] [Google Scholar]
  19. Simard J., Dauvois S., Haagensen D. E., Lévesque C., Mérand Y., Labrie F. Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer. Endocrinology. 1990 Jun;126(6):3223–3231. doi: 10.1210/endo-126-6-3223. [DOI] [PubMed] [Google Scholar]
  20. Sánchez L. M., Vizoso F., Díez-Itza I., López-Otín C. Identification of the major protein components in breast secretions from women with benign and malignant breast diseases. Cancer Res. 1992 Jan 1;52(1):95–100. [PubMed] [Google Scholar]
  21. Weaver C. A., Springer P. A., Katzenellenbogen B. S. Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens: comparison of effects on the native gene and on pS2-chloramphenicol acetyltransferase fusion genes transfected into MCF-7 human breast cancer cells. Mol Endocrinol. 1988 Oct;2(10):936–945. doi: 10.1210/mend-2-10-936. [DOI] [PubMed] [Google Scholar]
  22. Wrensch M. R., Petrakis N. L., Gruenke L. D., Ernster V. L., Miike R., King E. B., Hauck W. W. Factors associated with obtaining nipple aspirate fluid: analysis of 1428 women and literature review. Breast Cancer Res Treat. 1990 Jan;15(1):39–51. doi: 10.1007/BF01811888. [DOI] [PubMed] [Google Scholar]
  23. Zumoff B. Hormonal profiles in women with breast cancer (review). Anticancer Res. 1988 Jul-Aug;8(4):627–636. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES